Acquisition Announced

Curium US Holdings acquisition of Lantheus Holdings

US$8bn equity value

Announced 3 Aug 2026 · NASDAQ: LNTH · US$102.50 cash per share · 38% premium

Advisers

Lantheus Holdings

Target

Fairness opinion

Curium US Holdings

Acquirer

Target
Lantheus Holdings
Acquirer
Curium US Holdings
Target based in
United States
Buyer based in
United States
Sector
Radiopharmaceuticals
Tags
Radiopharmaceuticals, Diagnostics, Pharma

In the league tables

Similar deals

All radiopharmaceuticals deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.